Abstract 16154: Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Presence and Severity of Coronary Disease and is an Independent Predictor of Adverse Cardiovascular Outcomes

Danny J. Eapen,Pankaj Manocha,Riyaz Patel,Hatem Al-Kassem,Muhammad Hammadah,Ayman Samman-Tahhan,Nima Ghasemzadeh,Mohammad Tarek Kabbany,Mohammad M. Asfari,Neal Bhatia,Mohamed Khayata,Suliman Alradawi,Emir Veledar,Tomasz Pielak,Christian W. Thorball,Kobina Wilmot,Rs Yendamuri,Michael M Halista,Ngoc-Anh Le,Stamatios Lerakis,Laurence Sperling,Arshed A. Quyyumi

Abstract 16154: Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Presence and Severity of Coronary Disease and is an Independent Predictor of Adverse Cardiovascular Outcomes

2012

Introduction: Soluble urokinase plasminogen activator receptor (suPAR) is an emerging inflammatory and immune biomarker. Recent studies have demonstrated a positive association of suPAR with incide...

Keywords:

SuPAR
Gastroenterology
Disease
Internal medicine
Diabetes mellitus
Urokinase Plasminogen Activator
Medicine
Cardiology
Receptor
Immune system
Coronary artery disease
Biomarker (medicine)
Myocardial infarction

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations